Compare Organon Pharma Indonesia Tbk. (SCPI) vs Teknologi Karya Digital Nusa Tbk. (TRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Teknologi Karya Digital Nusa Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Teknologi Karya Digital Nusa Tbk. trades at Rp100 (market cap 298.08B, 16.25M 24h volume). The key difference: Teknologi Karya Digital Nusa Tbk. is far larger — about 2.9× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TRON | |
|---|---|---|
Market Cap | 104.4B | 298.08B |
Volume | — | 16.25M |
Lot | — | 162.51K |
Turnover | — | 1.6B |
Average Price | — | 98.17 |
Value | — | 1.6B |
Indicative Equilibrium Price | — | 100 |
Indicative Equilibrium Volume | — | 1.79K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Teknologi Karya Digital Nusa Tbk.
PT Teknologi Karya Digital Nusa Tbk (formerly PT Damai Harapan Sentosa) (the Entity) wasestablished based on Notarial Deed No. 25 dated January 7, 2011 of Tjoa Karina Juwita SH., Notaryin Jakarta. The Entity started its commercial operations in 2015. PT Teknologi Karya Digital Nusa Tbk is the parent entity, whereas David Santoso is the ultimate beneficial owner starting from 2020.
Read more on TRON →
